Biomarkers Europe 2024

30 September - 01 October 2024 | Basel, Switzerland

Gain insights into Biomarker approaches & accelerate timelines in drug development for oncology and immuno-related therapies

Presentation Speaker
Overview Biomarkers Precision Oncology
+co-located event:
Spatial Biology

Formed of the 3rd Annual Biomarker Europe and 2nd Annual Precision Oncology Europe Congresses, Biomarkers Europe 2024 is focused on driving the advancement of biomarkers within the fields of oncology and immunotherapy.

The co-located events provide a specialized platform to explore the most innovative technologies and approaches for biomarker validation & Identification, biomarker analysis, applications in precision oncology & patient treatment in clinical trials.

With over 50 presentations, these two-day congresses provide multiple opportunities for engaging scientific insights, valuable networking, and interactive panel & workshop discussions.

Over 500 leading industry experts and clinicians will engage on biomarker end points, personalised patient treatment and companion diagnostics development including early detection technologies & liquid biopsies.

3rd Biomarkers Europe Congress

Addressing challenges in biomarker analysis to accelerate timelines in drug development including the role of safety and efficacy biomarkers . Discover novel approaches into optimising biomarker analysis through effective assay development, as well as utilising the latest multiplexed tools impacting biomarker research and validation.

  • Acquire knowledge about how biomarker approaches are utilized in drug discovery and translational sciences for oncology and immuno-related therapies.
  • Explore how companies accelerate timelines and reduce risk in drug development. Presentations consider the latest applications of Biomarker Analysis – Multiplex Technology Application & Translational Research in oncology & Immunological disorders
  • Gain insights into emerging bioanalysis approaches, assay development, and what can be translated in the clinic

Agenda at a Glance


Day One | Track 1: Application Of Multiplex Technology For Exploratory & Clinical Biomarkers In Translational Research

Day One | Track 2: Identification, Qualification & Validation Of Efficacy & Safety Biomarkers In Translational Studies

Day Two | Track 1: Data Driven Approaches For Biomarker Analysis

2nd Annual Precision Oncology Europe Congress

Bringing together experts In Oncology And Cancer Care, Clinical Research, and Drug Development To Explore application in diagnosis, stratification & prognosis in oncology, and advancing personalized treatment to improve patient outcomes.

  • Showcasing the latest technologies and clinical studies in multi-cancer early detection and minimal residual disease testing
  • Learn about molecular characterization of tumour for targeted therapy selection
  • Explore biomarker and companion diagnostics discovery, and development
  • Gain insights from genomics-enabled clinical trials for tailored cancer drug development

Agenda at a Glance


Day One: Multi-Cancer Early Detection Techniques & Companion Diagnostics for Precision Oncology

Day Two: Digital Technologies For Advancing Biomarkers In The Clinic & Personalized Patient Treatment  

3rd Annual Spatial Biology Europe Congress

Attendees of Biomarkers Europe 2024 also have access to Spatial Biology Europe 2024

Explore Spatial Biology Europe 2024: Unlocking Future Insights in Spatial Biology Research

Join leaders, experts and researchers at the 3rd Annual Spatial Biology Europe Congress, connecting global academic & research organisations as well as pharma representatives for high-level discussions on the latest innovations in spatial research & technologies. Forward looking visionary leaders will discuss the current state of the industry, market trends and future growth areas aiding the application of spatial technologies in the clinic.

  • Take a deep dive into image analysis, AI-powered imaging, and utilising digital pathology for spatial biology. Key opinion leaders will be providing insights into computational image analysis, multiplexed digital pathology, and the utilisation of AI & machine learning within spatial transcriptomic studies 
  • Discuss the latest innovations in spatial bioinformatics and data analytics. Presentations will delve into the use of spatial data in biology, modelling cell-cell communications, and computational algorithms for spatial analysis. A focused workshop will investigate how to overcome the challenges of spatial data integration
  • Gain comprehensive insights into novel application areas for spatial biology. This event will cover the applications of spatial data across a variety of therapeutic areas including neuroimmunology, oncology, cardiology and more. Discussions will also involve strategies for making spatially targeted therapeutics more precise
  • Hear from leading innovators utilizing spatial biology in pharma. See how leading pharmaceutical companies are beginning to integrate spatial biology into R&D to accelerate timelines and move towards the clinic

Agenda at a Glance


  • Day One | Track 1: Spatial Multi Omics Techniques & Approaches
  • Day One | Track 2: Image Analysis, AI-Powered Imaging & Digital Pathology for Spatial Biology
  • Day Two | Track 1: Spatial Bioinformatics, Data Analytics and Interpretation
  • Day Two | Track 2: Applications of Spatial Research & Technologies in Biology

What to Expect

500

leading pharma, biotech, & academic delegates

12
hours of presentations, discussions & interactive content
9
hours of networking breaks, including speed networking & refreshments
100
hours of pre-arranged 1-2-1 meetings, facilitating business growth
Interactive Presentations
Exhibition Hall
Networking Drinks
Poster Display
Event App Swapcard

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences

  • Engaging Thought Leadership

    Over 50 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
  • Global Technological Showcase

    An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
  • Networking Emphasis

    Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
  • Innovative Poster Displays

    Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions

Companies Represented Include

Meet Our Expert Speakers

The event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data, and industry outlooks. Below were some of the featured speakers at Biomarkers Europe 2023: 14 - 15 November 2023, Berlin, Germany

All Speakers

Akanksha Goyal
Principal Investigator (GLP) and Senior Scientist,
CSL Behring Innovation GmbH
Alain van Gool
Professor Personalized Healthcare,
Radboud university medical center
Anna Frömming
Director Translational Research,
TME Pharma
Arcangelo Liso
Professor of Medicine,
University of Foggia
Brian Lockhart
Global Head of Companion Diagnostics,
Servier Monde
Christian Garde
Director,
Evaxion Biotech
Christian Ruiz
Senior Lecturer; Chief Scientific Officer,
University of Basel; Moonlight AI
Emmanuel Valentin
Vice President, Translational Medicine,
Imcheck Therapeutics
Francesca Maria Bosisio
Professor,
KU Leuven University
Guillaume Desachy
Statistical Science Director,
AstraZeneca
Ken C. N Chang
Senior Director, Translational Biomarkers,
Merck Sharpe & Dohme
Kirill Pevzner
Chief Technical Officer & Co-founder,
Protai
Nolwen Guigal-Stephan
Head of Clinical Biomaker Development,
Servier Monde
Priyank Patel
Senior scientist,
www.boehringer-ingelheim.com
Sari Pesonen
Chief Scientific Officer,
Valo Therapeutics
Tushar Tomar
Director Bioanalytics,
LAVA Therapeutics

Interested in Sponsoring?

Oxford Global’s range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.

Learn more

Latest Resources

Unveiling the Essential Criteria for Validating Clinical Biomarkers: A Comprehensive Guide

Biomarkers by Oxford Global will explore the essential criteria for validating clinical biomarkers, shedding light on the steps and challenges involved.

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.

Early Diagnostic Blood Biomarker for Dementia Identified Using Proteomics

The team hopes to develop the biomarker into a test that could be used in GP surgeries. Early prediction of dementia could be a gamechanger for new Alzheimer's therapies.

Plan Your Visit

Venue not confirmed
Information regarding accommodation for this event will be added soon

We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.

As we continue to move forward with hosting our events in-person in 2024, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.

Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.

Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.

If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Biomarkers Europe 2024 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.

Register Your Interest

Submit your details and a member of our team will be in touch